(Q46714706)

24 December 2017

title

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians (English)

1 reference

24 December 2017

1 reference

1 reference

1

1 reference

24 December 2017

John Scott

object named as

John A Scott

3

0 references

David Kupfer

5

object named as

David J Kupfer

1 reference

24 December 2017

author name string

Ellen Frank

2

1 reference

24 December 2017

Scott Turkin

4

1 reference

24 December 2017

publication date

1 October 2005

1 reference

24 December 2017

published in

Bipolar Disorders

1 reference

24 December 2017

volume

7

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

424-430

1 reference

24 December 2017

Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Obesity as a correlate of outcome in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Burden of general medical conditions among individuals with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Lower high-density lipoprotein cholesterol and increased omega-6 polyunsaturated fatty acids in first-degree relatives of bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Serum leptin and cholesterol levels in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

The metabolic syndrome: more than the sum of its parts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Impaired glucose tolerance, insulin resistance and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Relation of weight change to changes in atherogenic traits: The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Metabolic syndrome: dietary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

Prevalence of obesity and weight change during treatment in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2005.00234.X

10.1111/J.1399-5618.2005.00234.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16176435

1 reference

24 December 2017